Published in J Virol on March 28, 2016
Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment. Clin Infect Dis (2016) 0.81
Cytomegalovirus and HIV: A Dangerous Pas de Deux. J Infect Dis (2016) 0.79
Factors Associated with the Size of HIV DNA Reservoir. Chin Med J (Engl) (2017) 0.75
Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog (2017) 0.75
A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo. AIDS (2017) 0.75
Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc (2017) 0.75
Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals. Med Microbiol Immunol (2017) 0.75
Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy. AIDS (2017) 0.75
HIV preferentially infects HIV-specific CD4+ T cells. Nature (2002) 9.28
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med (2009) 8.45
The challenge of finding a cure for HIV infection. Science (2009) 8.41
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med (2010) 5.36
Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A (2008) 4.71
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med (2013) 4.26
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med (2010) 3.81
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest (2005) 3.62
Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One (2013) 3.53
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol (2008) 3.04
HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep (2012) 2.71
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis (2012) 1.86
Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. AIDS (2013) 1.60
Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol (2011) 1.55
Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis (2013) 1.53
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection. PLoS One (2010) 1.50
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol (2014) 1.30
A novel PCR assay for quantification of HIV-1 RNA. J Virol (2013) 1.25
Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection. PLoS Pathog (2009) 1.24
Immune activation and HIV persistence: considerations for novel therapeutic interventions. Curr Opin HIV AIDS (2013) 1.12
Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J Infect Dis (2012) 1.10
The Sordid Affair Between Human Herpesvirus and HIV. J Infect Dis (2015) 1.02
Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis (2013) 0.93
Residual inflammation and viral reservoirs: alliance against an HIV cure. Curr Opin HIV AIDS (2016) 0.90
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection. Curr HIV/AIDS Rep (2016) 0.87
Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr (2016) 0.81